http://hdl.handle.net/1842/2031 2013-06-18T09:40:19Z 2013-06-18T09:40:19Z Laurie, Graeme Hunter, Kathryn Cunningham-Burley, Sarah Haddow, Gill http://hdl.handle.net/1842/2450 2013-04-10T10:08:37Z 2007-01-01T00:00:00Z

Title: Tackling Community Concerns about Commercialisation and Genetic Research: A Modest Interdisciplinary Proposal Authors: Laurie, Graeme; Hunter, Kathryn; Cunningham-Burley, Sarah; Haddow, Gill Abstract: In recent years, there has been a rise in the creation of DNA databases promising a range of health benefits to individuals and populations. This development has been accompanied by an interest in, and concern for the ethical, legal and social aspects of such collections. In terms of policy solutions, much of the focus of these debates has tended to be on issues of consent, confidentiality and research governance. However, there are broader concerns, such as those associated with commercialisation, which cannot be adequately addressed by these means. This article focusses on the health-wealth benefits that DNA databases promise, and discusses the competing public and private interests at stake.

2007-01-01T00:00:00Z Laurie, Graeme Mason, J K http://hdl.handle.net/1842/2445 2013-04-10T09:53:21Z 2003-01-01T00:00:00Z

Title: Misfeasance in Public Office: An Emerging Medical Law Tort? Authors: Laurie, Graeme; Mason, J K Abstract: The authors draw on two notable cases, Akenzua v. Secretary of State for the Home Department, and Palmer v Tees Health Authority, to which the outcome has prompted the article discussing misfeasance as an emerging medical law tort. Although similarities exists in both cases, they are quite different, with the former argued on the basis of misfeasance in public office, and the latter on negligence. These are examined in detail, together with their possible impact for an NHS Trust.

2003-01-01T00:00:00Z Laurie, Graeme http://hdl.handle.net/1842/2442 2008-08-18T10:35:36Z 2004-01-01T00:00:00Z

Title: Patenting Stem Cells of Human Origin Authors: Laurie, Graeme Abstract: The author discusses the impact of the European Union's Directive for the legal protection of biotechnological inventions (Directive 98/44/EC of 6 July 1998. Specific attention is given to the absence from provisions of the mention of human stem cells, which generated significant ethical and legal debate in the UK, and globally, at that time. The paper considers the robustness of European patent provisions, and focusses on the potential consequences in the continuing debate of human stem cells.

2004-01-01T00:00:00Z